US EditionPublished • loading... • Updated
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.26 Average PT from Analysts
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.26 Average PT from Analysts
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty-two analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and thirteen have given a buy […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
